Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Rubius Therapeutics, Inc. - Common Stock (NY:ONLN)

49.39 +0.00 (+0.00%)
Official Closing Price Updated: 8:00 PM EDT, Jun 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,108
Open 49.64
Bid (Size) 48.35 (52)
Ask (Size) 50.41 (50)
Prev. Close 49.39
Today's Range 49.39 - 49.65
52wk Range 36.15 - 51.60
Shares Outstanding 15,800
Dividend Yield 0.23%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Abercrombie Is Hot Again — Here's Why Your Retail ETF Didn't Get The Memo
Abercrombie & Fitch's Q1 results beat expectations, causing a 30% stock surge. 
Via Benzinga
Topics ETFs
What's Going On With Buckle Stock On Friday?
Buckle, Inc. (BKE) shares down in premarket after reporting Q1 results. Beats EPS estimates, with sales up 3.7% and online sales up 4.5%. 
Via Benzinga

Performance

YTD
+9.5%
+9.5%
1 Month
+2.0%
+2.0%
3 Month
+12.3%
+12.3%
6 Month
+8.3%
+8.3%
1 Year
+22.9%
+22.9%

More News

Read More
Retail ETFs Rattle As Tariffs, Yields, Consumer Caution Pressure Big-Box Stocks
Via Benzinga
Topics ETFs
Carvana Sets Ambitious Long-Term Target, Delivers Strong Q1 Results: Retail Skeptical
Via Stocktwits
Topics Government World Trade
Exposures Political Tariff
Amazon, Meta, Microsoft Earnings Put Dan Loeb's Portfolio To The Test
Via Benzinga
Ebay Expands Global Payments Acceptance With Checkout Partnership: Retail Mood Optimistic
Via Stocktwits
Topics World Trade
Exposures Tariff
Why Is eBay Stock Trading Higher On Wednesday?
Via Benzinga
Temu Parent PDD Holdings Drops After Q4 Revenue Miss: Details
Via Benzinga
Dan Loeb's Portfolio Feels The Strain As Tesla, Amazon, PG&E Lose Ground
Via Benzinga
eBay's Growth Story Intact? Analyst Sees Strength But Warns Of Tariff And FX Challenges
Via Benzinga
Alibaba Jumps Post Q3 Earnings: ETFs To Buy
Via Talk Markets
Topics ETFs Stocks / Equities
Apple Focuses On Alibaba, Baidu Partnership In Race To Bring AI Features To China by Mid-2025
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Dan Loeb's Amazon Stake Moves: A Look At His Trading Shifts
Via Benzinga
Amazon Stock In Focus Ahead Of Q4 Earnings As Retail Investors Bank On Strong Holiday Sales, Watch For Cloud Updates
Via Stocktwits
Amazon Cuts More Jobs in Cost-Saving Push: Report
Via Benzinga
Amazon's AWS Boosts Federal Support With Booz Allen Collaboration On Cybersecurity And AI
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Amazon Pauses Drone Deliveries In Texas, Arizona After Crashes, Plans Safety Upgrades
Via Benzinga
Amazon Web Services Expands In Asia Pacific With $5 Billion Investment In Thailand Region
Via Benzinga
Alibaba Cloud Joins Forces With Ex-Google Exec's Unicorn To Boost AI Models
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
AskSlim Market Week - Friday, Dec. 20
Via Talk Markets
Topics ETFs Futures Stocks / Equities
eBay Expands Klarna Partnership: Buy Now, Pay Later Goes Big In Europe
Via Benzinga
US-Listed Chinese Stocks Give Up Gains In Anticipation Of More Stimulus
Via Benzinga
5 ETFs For Smart Holiday Season Investing
Via Talk Markets
Topics ETFs
Amazon Hits All-Time Highs, Eyes Best 2-Year Rally Since 2010: Cyber Season Marks Record Sales, AWS Shines With AI Innovations
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Amazon's AWS CEO Teases Major AI Advancements
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence

Frequently Asked Questions

Is Rubius Therapeutics, Inc. - Common Stock publicly traded?
Yes, Rubius Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Rubius Therapeutics, Inc. - Common Stock trade on?
Rubius Therapeutics, Inc. - Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Rubius Therapeutics, Inc. - Common Stock?
The ticker symbol for Rubius Therapeutics, Inc. - Common Stock is ONLN on the New York Stock Exchange
What is the current price of Rubius Therapeutics, Inc. - Common Stock?
The current price of Rubius Therapeutics, Inc. - Common Stock is 49.39
When was Rubius Therapeutics, Inc. - Common Stock last traded?
The last trade of Rubius Therapeutics, Inc. - Common Stock was at 06/18/25 08:00 PM ET
What is the market capitalization of Rubius Therapeutics, Inc. - Common Stock?
The market capitalization of Rubius Therapeutics, Inc. - Common Stock is 780.39K
How many shares of Rubius Therapeutics, Inc. - Common Stock are outstanding?
Rubius Therapeutics, Inc. - Common Stock has 780K shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.